Product
Atenativ
1 clinical trial
1 indication
Indication
Antithrombin DeficiencyClinical trial
A Multicentre, Prospective, Open-label, Uncontrolled Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or DeliveryStatus: Recruiting, Estimated PCD: 2025-06-01